Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 4.89M | $357.0M | 12.76% | -692.4K | 2026-06-30 |
| BlackRock, Inc. | 2.47M | $180.0M | 6.44% | +194.1K | 2026-06-30 |
| RA CAPITAL MANAGEMENT, L.P. | 2.45M | $179.0M | 6.39% | -- | 2026-06-30 |
| JPMORGAN CHASE & CO | 1.88M | $139.0M | 4.89% | +294.7K | 2026-06-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.88M | $137.0M | 4.89% | +326.0K | 2026-06-30 |
| WELLINGTON MANAGEMENT GROUP LLP | 1.74M | $127.0M | 4.54% | +6.0K | 2026-06-30 |
| STATE STREET CORP | 1.65M | $120.0M | 4.30% | -49.4K | 2026-06-30 |
| Vestal Point Capital, LP | 1.55M | $113.0M | 4.04% | +850.0K | 2026-06-30 |
| Atlas Venture Life Science Advisors, LLC | 1.51M | $110.0M | 3.95% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.37M | $100.0M | 3.57% | -6.4K | 2026-06-30 |
